Physician profile
Mathew M John
NPI 1497740229
$2,349.63
in general payments reported to CMS, 2019-2025
17 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $37.96 · 2021: $70.09 · 2022: $1,635 · 2024: $18.93 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,652.62 | 2022-2025 | |
| Kerecis Limited | $173.57 | 2019 | |
| Bone Support INC. | $150.82 | 2025 | Cerament G, Ceramentbone Void Filler |
| Sandoz INC. | $82.97 | 2019-2020 | |
| Dynasplint Systems INC. | $58.06 | 2019-2025 | Dynasplint |
| Ani Pharmaceuticals, INC. | $36.93 | 2025 | Oxistat |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $26.80 | 2020-2021 | |
| Osteomed LLC | $25.26 | 2019 | |
| Horizon Therapeutics Plc | $21.85 | 2021 | |
| Tenex Health INC. | $19.29 | 2021 | |
| Fidia Pharma USA INC. | $18.93 | 2024 | Hymovis, Triluron, Hyalgan |
| Pacira Pharmaceuticals Incorporated | $18.30 | 2019 | |
| Amniox Medical, INC. | $15.38 | 2019 | |
| Zyla Life Sciences, INC. | $13.92 | 2019 | |
| Reprise Biomedical, INC. | $13.40 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $11.29 | 2019 | |
| Paragon 28, INC. | $10.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.